- News & Events
- Professional Development
|Make Your Voice Heard on MS Treatment|
Make Your Voice Heard on MS Treatment
Dear Members of the CMSC:
Please read the information below and help the MS Coalition in this important advocacy activity by directing your patients to this survey. As you may know, the CMSC is a member of the MS Coalition* which is working with the Institute for Clinical and Economic Review (ICER).
ICER is currently conducting a review of disease-modifying therapies for relapsing-remitting and primary progressive forms of multiple sclerosis. Insurers may use ICER recommendations to develop or change their approved drug lists, which could potentially improve or restrict access to MS medications for people living with MS. To ensure that people living with MS have direct input into their analysis of the use and effectiveness of disease-modifying therapies, the MS Coalition contacted ICER.
As a result of our discussions, a joint survey has been developed to gain valuable patient input into the use of these drugs.
Your patients’ input is extremely vital. Their experience matters. In just five to ten minutes, they can provide valuable input by completing this short, anonymous survey. Your assistance is vital to this effort to determine whether we can help improve access to and satisfaction with MS drug therapy.
The survey may be accessed by your patients using the link below. The survey link (below) will be active from August 31st through September 14th. This survey is limited to those of 21 years or older.